drugset / Trial / NCT00003977
Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer
Phase 1
Completed
Steward St. Elizabeth's Medical Center of Boston, Inc.
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients with recurrent or persistent cervical cancer that cannot be treated with surgery or radiation therapy.
Timeline
- Start
- 1999-11
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | human papillomavirus 16 E7 peptide | Peptide | — | Subcutaneous |